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Bioscience: How one industry won the pandemic and will change us all
Sonya Swink
The pandemic has exploded interest in biology. With record amounts of funding to make
the world more resilient, the industry is booming.


No longer confined to 9th grade textbooks, our everyday lives are affected by biological
sciences.


But the threat of too much money pouring into the industry means competition, and
more companies competing means the stakes are higher.


“Bioscience, it sounds risky,” said Abby Nevills, an 11-year-old lip balm maker in
Southern California.
“People then have to pay the people who have not technically any money to do the
idea, but they're just figuring out the science. It’s like when I mess up one of my lip
colors, I have to start all over."


A Bad Reputation
"The government noted before Covid-19 that biotech, pharma ranked dead last in terms
of respect by Americans," said Hartaj Singh, an analyst of the industry for Oppenheimer
& Co.


"But it is truly an All-American and booming industry," stated Singh.



A lot of change to privacy and to making life individualized, just as social media and
personal computers did some decades ago, is cause for concern in addition to price
fears when Americans hear health and science are growing industries. Throughout the
year, misinformation by and about the scientific community has spread about
coronavirus and other subjects. The American Institute of Biological Sciences stated
their stance on a support of evidence-based policy going forward, signed by 26
adjoining organizations.



Yet, bioscience is spurring leases, jobs and more. Billions in dollars are going to
startups and corporations alike to make our world more resilient. In the US, that's great
news for an economy that was thwarted by a deadly virus.

The Next Great Industry
Bioscience is resistant to pandemics. Startups and corporations alike got tons in private
and public dollars this year. Over $6.6 billion was raised for health innovation funding in
the third quarter of 2020, a record, according to StartUp Health Magazine.


Gilead alone saw over $7 billion in sales in 2020, seeing its own stock upgraded
according to Bloomberg.
The pandemic has been booming for startups and corporations in the life sciences
industry.
Although there's issues in competition actually slowing innovation, there’s much good in
the industry. And it’s only growing. Biotech research and development is projected to
grow jobs by 12 to 14% in the next decade, according to the US Bureau of Labor
Statistics.
Venture capital, that is funding from large groups for life science startups or ideas, hit
over 9.9 billion in 2020, according to Newmark Knight Real Estate analytics.


Denver: Just One Small Market Growing from Bioscience Investment


Much like Silicon Valley, where tech jobs grew the California region into a place for
some of the best-paying jobs and most expensive houses in the US, so does
bioscience.
The main hub for bioscience is in Cambridge, Massachusetts. But with the explosion of
people looking to invest in new businesses, smaller cities are growing their industries.
Colorado is one small market getting a boost.




Before 2017, Colorado was a niche market for anything in science. By then, lab space
was running out, so the state’s Office of Economic Development and International Trade
(OEDIT) focused on Bioscience as one of the state’s best bets, and started providing
grants for companies and researchers to move to the Denver-Boulder area. By October
of 2020, the state finally hit ranking as one of the hubs for bioscience jobs and growth.



For the first time this year, it hit top rankings by CBRE, a real estate investment firm, for
being a top life sciences cluster.

“In at least the last six months, I’ve seen just a really healthy steady flow of
bioscience companies interested in moving to Colorado are expanding here,”
said Reid Aronstein, Senior Global Business Development Manager at OEDIT.


Two places are the Fitzsimons Innovation Campus, where the University of Colorado
Hospital, Children’s Hospital and the Veteran Affairs Hospital reside, and the University
campus itself in Boulder. Recently Astra-Zeneca relocated one of its companies to
Colorado due to receiving an OEDIT grant of about $2 million per $2 million invested,
bringing with it new lab space and 300 jobs to Boulder.


Individualized Medicine, Food and More
“One area that we can foresee moving into is more individually-tailored therapeutics.
That could make one drug targeted toward them more successful than another,” said
Dr. Nicole Gatto, epidemiologist and Associate Professor at Claremont Graduate
University.


Each product will be made for each person, creating an industry that might rival and
become the next Silicon Valley in the next few decades.

Highlight on Lab Space: A Boon for Real Estate


“Here’s the thing about life sciences: You can’t do it at home,” said Maria Gotsch from
the Partnership for New York. “Not every job is in a lab, but a lot of them are.
-That’s great news for real estate and researchers.




And if the government continues to help like it has over the past five years, the failure
rate on bioscience companies will go down, making it more attractive for investors to
look at compared to a tech company. NIH funding grew by 29.7% between 2015 and
2019, or an annual average of 6.7%. Projections for fiscal year 2020 show another 6.0%
growth.



Although the growth of jobs brings concerns about gentrification to these hubs, such as
Denver which has the highest rate of bachelor’s degrees behind Boston, it will also spur
more taxes to go toward social services and likely better health care overall, as most
research is housed inside hospital systems.

The Future to Create



Within the next decades, things like lab-grown blood, clothes that dissolve in the ocean
and pills for each person's unique gut flora will be reality, not science fiction. And for
better or worse, we will have ushered in Life 2.0.
The next great industry might have to be more tightly regulated, add more public
funding or be scaled back, just like tech, but it promises nothing short of total change.

